Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
http://link.springer.com/article/10.1007/s11938-019-00222-9/fulltext.html
Reference80 articles.
1. Duijvestein M, Battat R, Vande Casteele N, D'Haens GR, Sandborn WJ, Khanna R, et al. Novel therapies and treatment strategies for patients with inflammatory bowel disease. Curr Treat Options Gastroenterol. 2018;16(1):129–46. https://doi.org/10.1007/s11938-018-0175-1 .
2. Van Assche G. Optimizing biologic therapy for treatment of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9(7):462–4.
3. Roda G, Jharap B, Neeraj N, Colombel JF. Loss of response to anti-TNFs: definition, epidemiology, and management. Clin Transl Gastroenterol. 2016;7:e135. https://doi.org/10.1038/ctg.2015.63 .
4. Yanai H, Hanauer SB. Assessing response and loss of response to biological therapies in IBD. Am J Gastroenterol. 2011;106(4):685–98. https://doi.org/10.1038/ajg.2011.103 .
5. Vande Casteele N, Khanna R, Levesque BG, Stitt L, Zou GY, Singh S, et al. The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease. Gut. 2015;64(10):1539–45. https://doi.org/10.1136/gutjnl-2014-307883 .
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease;International Journal of Environmental Research and Public Health;2024-08-28
2. The Impact of Baohuoside I on the Metabolism of Tofacitinib in Rats;Drug Design, Development and Therapy;2024-03
3. Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab;The Journal of Applied Laboratory Medicine;2023-09-02
4. Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish;Life Sciences;2023-09
5. Switching Among Biosimilars: A Review of Clinical Evidence;Frontiers in Pharmacology;2022-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3